FMR LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$2,822,000
-6.2%
2,785,0000.0%0.00%
Q4 2020$3,009,000
-57.7%
2,785,000
-59.5%
0.00%
-100.0%
Q3 2020$7,115,000
-6.3%
6,885,0000.0%0.00%0.0%
Q2 2020$7,590,000
+8.0%
6,885,000
-0.9%
0.00%0.0%
Q1 2020$7,029,000
-43.9%
6,945,000
-36.5%
0.00%0.0%
Q4 2019$12,522,000
+0.3%
10,945,0000.0%0.00%0.0%
Q3 2019$12,482,000
-3.6%
10,945,0000.0%0.00%
-50.0%
Q2 2019$12,943,000
-3.3%
10,945,000
+10.6%
0.00%0.0%
Q1 2019$13,383,000
+26.3%
9,900,0000.0%0.00%
+100.0%
Q4 2018$10,594,000
+0.9%
9,900,000
-1.0%
0.00%0.0%
Q3 2018$10,500,00010,000,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders